# OnCo record human-normal-immunoglobulin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/human-normal-immunoglobulin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "human-normal-immunoglobulin" ;
  schema:name "Human normal immunoglobulin (IVIg)"@en ;
  schema:alternateName "human normal immunoglobulin (IVIg)"@en, "human normal immunoglobulin"@en, "IVIg"@en, "intravenous immunoglobulin"@en, "Privigen"@en, "Kiovig"@en, "Privigen / Kiovig" ;
  schema:description "Intravenous immunoglobulin is pooled antibody from many blood donors. People with chronic lymphocytic leukaemia or myeloma whose own antibody levels have collapsed, and who keep getting bacterial infections despite antibiotics, receive it as replacement."@en ;
  schema:url <https://onco.cc/drugs/human-normal-immunoglobulin/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/privigen>, <https://www.ema.europa.eu/en/medicines/human/EPAR/kiovig> ;
  onco:status "approved" ;
  onco:tag "ema-register", "supportive" ;
  onco:modality "Pooled human polyclonal IgG antibody preparation (intravenous immunoglobulin)" ;
  onco:approval "EU 2006: Replacement therapy in hypogammaglobulinaemia with recurrent bacterial infections in CLL (after failed antibiotic prophylaxis) and plateau-phase multiple myeloma (after failed pneumococcal immunisation); primary immunodeficiency" ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:companies <https://onco.cc/companies/csl/>, <https://onco.cc/companies/takeda/> .